Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Immunology Webinars & Conferences

Europe & UK
Asia Pacific & Middle East
Canada

Immunology & Immunotherapies 2021

About Webinar

We invite all the participants from all across the globe to attend “Immunology & Immunotherapy” conference during May 11-2021 Webinar  which includes prompt keynote presentations, poster and oral talks. This conference plays a Global platform for biomedical companies, clinical research divisions, professionals, specialists, consultants, doctors, scholars and students to frame a new relationship and build up the Knowledge. This is a wonderful   opportunity for all the delegates to interact with the top grade world class Scientists. The particular members can confirm their participation through Registrations.

Theme: Innovative therapies for a better immune system

Target audience:

  • Immunology students
  • Directors
  • CEO
  • President
  • Research scientists
  • Organizations
  • Vice-president
  • Eminent personalities
  • Post-docs
  • Associations heads and Professors
  • Immunology laboratory heads
  • Students
  • Clinical Immunology Researchers and the other affiliates related to the area of Immunology and immunotherapy.

Tracks/ Sessions

Track 1: Allergy and Therapies

The ever expanding pollution has generate allergic responses a regular issue feedback  in the urban life of human being. Allergy is a hypersensitive reaction of the immune system composed by several origins such as environmental factors, drugs, foods etc. Allergy & Therapy presents a spectrum of exciting information on different approaches adopted and their possible conclusion in allergy research including new action in diagnosis, therapy and determent of allergic diseases

Track 2: Autoimmune Disorders

Immune system disorders element abnormally low activity or over activity of the immune system. In cases of immune system overactivity, the body attacks and damages its owned tissues (autoimmune diseases). Immune deficiency diseases reduction the body's ability to fight invaders, create vulnerability to infections.

In response to an unknown cause, the immune system may begin generating antibodies that rather of fighting infections, attack the body's own tissues. Treatment for autoimmune diseases commonly focuses on reducing immune system activity.

Examples of autoimmune diseases :

  • Rheumatoid arthritis.

  • Inflammatory bowel disease (IBD).

  • Multiple sclerosis (MS).

  • Type 1 diabetes mellitus.

  • Guillain-Barre syndrome.

  • Psoriasis

Track 3: Immunologic Techniques, Microbial Control and Therapeutics

Immunologic techniques are used for:determine and detecting antibodies and antigens, absolve  immunoglobulin’s, lymphokines and other molecules of the immune system, Isolating antigens and other texture important in immunological action, Labelling antigens and antibodies, contain antigens and antibodies in tissues and cells, and fractionally immunocompetent cells, estimate for cellular immunity, Documenting cell-cell interactions, Initiating immunity and unresponsiveness, Transplanting tissues, Studying items closely related to immunity such as complement, reticuloendothelial system and others, Molecular techniques for studying immune cells and their receptors, Imaging of the immune system, Methods for production or their fragments in eukaryotic and prokaryotic cells.

Track 4: Clinical Immunology: Current & Future Research

Immunology is the branch of the medical and biological sciences which attract on the study of the immune system. Immunology plays an great role in the fields of organ transplantation, oncology, virology, Pathology, Microbiology, dermatology and  bacteriology, Clinical immunology is the study of diseases generate by disorders of the immune system (failure, aberrant action, and malignant growth of the cellular elements of the system). It also associate  in other diseases, where immune reactions play a factor in the pathology  and clinical features.

Track 5: Genetics Immunology & Vaccinology

The evasion and subversion of immune responses as infection has elucidated many attractive and ingenious pathways used by pathogens to survive, expand, and finally be transmitted to new hosts. These immune artifice mechanisms are of interest as they generally suggest ways to avoid pathogens from causing infection or disease. More frequently, they make us consider or evaluate the full strategy of vaccine or disease avoidence.

Track 6: Cellular Immunology and Latest Innovations

The reaction to pathogens is build by the intricate cooperation’s and exercises of the extensive number of different cell types combine with the immune reaction. The inborn immune reaction is the primary line of guard and arrive not long after pathogen introduction. It is concluded by phagocytic cells, for example, neutrophils and macrophages, cytotoxic common executioner (NK) cells, and granulocytes. The resulting versatile immune reaction incorporates antigen-explicit preservation components and may take days to create. Cell types with basic jobs in versatile insusceptibility are antigen-announce cells including macrophages and dendritic cells.

Track 7: Pediatric Immunology

Immunology has divert a prominent role in the history of medicine. Pediatric immunologists have concentrate on immune aberrations in pediatric disorders, especially those involving host defense mechanisms. These attempt have paid rich dividends in terms of fundamental ability of the immune system and major therapeutic advances, including 1)immunoglobulin therapy, 2) hematopoietic stem cell transplantation, and 3) gene therapy. Pediatric immunology as an formulated discipline emerged in the early 1950s, when pediatricians and the basic scientist colleagues began to focus on clinical and essential research association to immunodeficiency.

Track 8: Pathology and Immunology

Trypanosomiasis and the nervous system: Pathology and immunology : Damage to the nervous system appear in both African and American trypanosomiases , but it differs appreciable  in form and extent in each disease, and with particular strains and disease stages. With Trypanosoma brucei infections there is a progressive central nervous system (CNS) pathology which associate the meninges, choroid, blood-brain barrier, and immune pathological changes including perivascular infiltrations, astrocyte activation and alterations in the cytokine/mediator network. These innovation underly the altered behaviour in the late or secondary disease stages, prevalent in the chronic gambian form, indicate by hypersomnia leading, if untreated or if treatment is followed by reactive changes, to coma and death.

Track 9: Stem Cell Immunology

Cancer stem cell: (CSC) biology and tumor immunology have shaped our compassionate of tumorigenesis. However, we still do not fully explain why tumors can be contained but not eliminated by the immune system and whether limited CSCs are required for tumor propagation.Long latency or repitation periods have been described for most tumors. Conceptualize, this requires a subset of distructive cells which is capable of initiating tumors, but is neither cancel by immune cells nor able to grow straight into overt tumors.

Track 10: Allergy, Hypersensitivity and Asthma

ALLERGY: Allergy is developing in prevalence and pharmacotherapy alone cannot control the disease.Allergy Immunotherapy   activate immunological tolerance and changes the course of disease.

HYPERSENSTIVITY: All cancer chemotherapeutic agents, exclude altretamine, the nitrosoureas, and dactinomycin, have composed at least an isolated instance of a HSR. convinced drugs, such as L-asparaginase and mitomycin (administered intravesically), cause HSRs of significant degree in approximately 10% of patients.

ASTHMA: Asthma is a natural disease that influence 300 million people worldwide. Given the large number of   eosinophils   in the airways of people with mild asthma, and documented by data from murine models, asthma was long treated the hallmark T helper type 2 (TH2) disease of the airways.

Track 11: Haematopoietic and Lymphoid Malignancies And Immune System Development

Haematopoietic stem cells  reside in the medulla of the bone (bone marrow) and accept the unique capability to give rise to all of the disparate mature blood cell types and tissues. HSCs are self-renewing cells: when they separate , at least some of their daughter cells continue as HSCs, so the pool of stem cells is not depleted. In establish embryos, blood formation occurs in aggregates of blood cells in the yolk sac, called blood islands. As development advance, blood production occurs in the spleen, liver and lymph nodes.

lymphoid malignance:  Mature B-cell malignancies are entered often by errors in immunoglobulin gene variable–diversity–joining region recombination, somatic hyper mutation  and class-switch recombination that lead to chromosomal translocations. Dysregulation of the genes at the change breakpoints disrupts B-cell homeostasis by perturbing proliferation, apoptosis and differentiation.immune system development: Yet the immune system is almost immature at birth and has to evolve during a life of disclosure to multiple foreign challenges through childhood, via young and mature adulthood (including pregnancy), to the deterioration of old age

Track 12: Neuro Immunology

Neuro immunology is a field connecting neuroscience, the study of the nervous system, and immunology, the study of the immune system. Neuro immunologists seek to better explain the interactions of these two complex systems during advancement, homeostasis, and response to injuries.

Track 13: Vaccines for Immune Mediated Diseases

The use of immunosuppressive therapies for immune-mediated disease is combine with an elevated risk of infections and associated comorbidities. While many infectious diseases can commonly be prevented by vaccines, immunization rates in this specific patient population survive suboptimal, due in part to uncertainty about their efficacy or safety under these clinical situations.

Track 14: Child Immunization and Vaccination Viral Immunology

Babies are born with conservation against some diseases because their mothers pass antibodies to them before birth. Breastfeed babies survive to get more antibodies in breast milk. But in both cases, the safety is temporary.Immunization (vaccination) is a way to build immunity to (protection from) some diseases. This is done by using small amounts of a killed or exhusted germ that causes the disease.

Track 15: DNA & Synthetic Conjugate Vaccines Travel & Edible Vaccines

Conjugate antibodies, made up of a bacterial polysaccharide antigen cross- associated  to a bacterial protein, are among the best immunizations accessible today to avert bacterial diseases, for example, pneumococcal and meningococcal contaminations. Conjugate antibodies adjacent bacterial pathogens with a substantial number of serotypes, for example, Streptococcus pneumoniae, commonly cover just a few the current strains. Another recombinant DNA-based assembling modernization has been created to avert absolute bacterial diseases.

Track 16: Paediatric Vaccinations

The first dose is given at the age of 2 months, the second dose at the  age of 4 months, the third dose at the age of 6 to 18 months, and the fourth dose at age 4 to 6 years. Diphtheriatetanus, and acellular pertussis (DTaP) vaccine: Before age 7, children are given the DTaP preparedness. Five doses of DTaP are given.

Track 17: Animal & Plant-Derived Vaccines

The progress toward commercialization of plant-based vaccines takes plenty effort and time, but a few candidate vaccines for use in humans and animals are in clinical trials. This review examine plant engineering technologies and regulations applicable to the development of plant-based vaccines and provides an overview of human and animal vaccines directly under clinical trials.

Track 18: Geriatric Immunizations

The vaccination adjustment is now for the most part centered around the youthful (matured beneath 18)to a few degree the old (matured over 65) be that as it may, as opposing to youth inoculation programs, grown-up immunization isn't attention to be a normal welbeing  intercession. Vaccination in adults remains an underused public health approach in the promotion of healthy aging, and adult vaccination rates are still far down the target.

Track 19: Cancer Immunology and Immunotherapy

Hanahan and Weinberg described six distinct biological properties of cancer cells that facilitate tumor growth and metastasis. These properties were indicate to  the traditional hallmarks of cancer. Recent exploration further elucidated hallmarks including evasion of immune destruction by tumor cells that disrupt anticancer response pathways. This review discusses cancer immunology and new therapy strategies aimed at restoration of antitumor immune responses.

Track 20: Infectious Diseases, Emerging and Re-emerging Diseases: Confronting Future Outbreaks

Infectious diseases advance to impose uncertain burdens on global health and economies, a subject that lack of constant research and updates. In this sense, the objective of the display article was to review studies on the role of wild animals as reservoirs and dispersers of etiological agents of human toxic diseases in order to compile data on the cable wild animals and etiological agents  elobrate in zoonotic outbreaks. A systematic inspection was carried out using PRISMA guidelines, using the PubMed, Scopus and SciELO platforms as data banks. The discription used were “zoonosis”, “human infectious diseases” and “wild animals”.

To Collaborate Scientific Professionals around the World

Conference Date May 11-11, 2021

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by